• Explore /
  • Poster
  • / Association of the neutrophil-to-lymphocyte ratio prior to checkpoint blockade immunotherapy (CBI) or radiation plus CBI with overall survival in melanoma patients.

Association of the neutrophil-to-lymphocyte ratio prior to checkpoint blockade immunotherapy (CBI) or radiation plus CBI with overall survival in melanoma patients.

Abstract Poster

Authors

null

Terence Duane Rhodes

Intermountain Precision Genomics, Murray, UT

Terence Duane Rhodes, Gail Fulde, Robin Romero, Tyler Abraham, Bryce Moulton, Margaret Van Meter, Ramya Thota, Mark Andrew Lewis, Derrick S. Haslem, Lincoln Nadauld, Tyler Barker

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies

Sub Track

Immune Checkpoints and Stimulatory Receptors

Citation

J Clin Oncol 36, 2018 (suppl 5S; abstr 200)

DOI

10.1200/JCO.2018.36.5_suppl.200

Abstract #

200

Poster Bd #

K9

Abstract Disclosures

Similar Posters

First Author: Minke W. Lucas

First Author: Tanya Jindal

First Author: Juan José Soto

Poster

2023 ASCO Annual Meeting

RAF-inhibitor rechallenge therapy in BRAF aberrated pan-cancers: RE-RAFFLE study.

RAF-inhibitor rechallenge therapy in BRAF aberrated pan-cancers: RE-RAFFLE study.

First Author: Blessie Elizabeth Nelson